An investigation of the effect of thiamine pyrophosphate on cisplatin-induced oxidative stress and DNA damage in rat brain tissue compared with thiamine: Thiamine and thiamine pyrophosphate effects on cisplatin neurotoxicity

Human and Experimental Toxicology

Volumn 33, Issue 1, 2014, Pages 14-21

  Turan, M I ^a   Cayir, A ^a   Cetin, N ^b   Suleyman, H ^b   Turan, I Siltelioglu ^c   Tan, H ^a  

^a ATATÜRK UNIVERSITY   (Turkey)

^b ATATURK UNIVERSITY   (Turkey)

^c MINISTRY OF HEALTH   (Turkey)

Author keywords

Cisplatin; neurotoxicity; oxidants; rat; thiamine

Indexed keywords

8 HYDROXYL GUANINE; CISPLATIN; COCARBOXYLASE; DNA; GLUTATHIONE; GUANINE DERIVATIVE; LIPID; MYELOPEROXIDASE; OXIDIZING AGENT; SUPEROXIDE DISMUTASE; THIAMINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DNA DAMAGE; EXPERIMENTAL RAT; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

CISPLATIN; NEUROTOXICITY; OXIDANTS; RAT; THIAMINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CEREBRUM; CISPLATIN; DNA DAMAGE; INJECTIONS, INTRAPERITONEAL; LIPID PEROXIDATION; MALE; NERVE TISSUE PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; OXIDATIVE STRESS; OXIDOREDUCTASES; RANDOM ALLOCATION; RATS; RATS, WISTAR; THIAMINE; THIAMINE PYROPHOSPHATE; VITAMIN B COMPLEX;

EID: 84879405148     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327113485251     Document Type: Article

References (48)

1. Mollman JE. Cisplatin neurotoxicity. New Engl J Med. 1990 ; 322: 126-127 (Pubitemid 20023872)
2. Cavaletti G, Tredici G, Marmiroli P, Petruccioli MG, Barajon I, Fabbrica D. Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats. Acta Neuropathol. 1992 ; 84: 364-371
3. Grothey A. Oxaliplatin-safety profile: neurotoxicity. Semin Oncol. 2003 ; 30: 5-13 (Pubitemid 37259547)
4. Grothey A, Goldberg RM. A review of oxaliplatin and its clinical use in colorectal cancer. Expert Opin Pharmacother. 2004 ; 5: 2159-2170 (Pubitemid 39406117)
5. van der Hoop RG, Vecht CJ, van der Burg ME, et al. Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer. New Engl J Med. 1990 ; 322: 89-94 (Pubitemid 20023866)
6. Cavaletti G, Marmiroli P. Chemotherapy-induced peripheral neurotoxicity. Expert Opin Drug Saf. 2004 ; 3: 535-546 (Pubitemid 39530207)
7. Windebank AJ, Smith AG, Russell JW. The effect of nerve growth factor, ciliary neurotrophic factor, and ACTH analogs on cisplatin neurotoxicity in vitro. Neurology. 1994 ; 44: 488-494 (Pubitemid 24098149)
8. Tomiwa K, Nolan C, Cavanagh JB. The effects of cisplatin on rat spinal ganglia: a study by light and electron microscopy and by morphometry. Acta Neuropathol. 1986 ; 69: 295-308 (Pubitemid 16134891)
9. Schmidt Y, Unger JW, Bartke I, Reiter R. Effect of nerve growth factor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic (db/db) mice. Exp Neurol. 1995 ; 132: 16-23
10. Carozzi VA, Canta A, Oggioni N, et al. Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies. Exp Neurol. 2010 ; 226: 301-309
11. Nabavi SF, Habtemariam S, Jafari M, Sureda A, Nabavi SM. Protective role of gallic acid on sodium fluoride induced oxidative stress in rat brain. Bull Environ Contamin Toxicol. 2012 ; 89: 73-77
12. Kawai Y, Nakao T, Kunimura N, Kohda Y, Gemba M. Relationship of intracellular calcium and oxygen radicals to cisplatin-related renal cell injury. J Pharmacol Sci. 2006 ; 100: 65-72 (Pubitemid 43161616)
13. Yilmaz HR, Iraz M, Sogut S, et al. The effects of erdosteine on the activities of some metabolic enzymes during cisplatin-induced nephrotoxicity in rats. Pharmacol Res. 2004 ; 50: 287-290 (Pubitemid 38844483)
14. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis. 2000 ; 21: 361-370 (Pubitemid 30137921)
15. Pavia DL, Gary ML, George SK, Randall GE. Introduction to organic laboratory techniques. 4 ed. Belmont, CA, USA: Thomson Brooks/Cole, 2006, pp. 292-312. Belmont, CA, USA: Thomson Brooks/Cole ; 2006, pp. 292-312 :
16. Comin-Anduix B, Boren J, Martinez S, et al. The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study. Eur J Biochem. 2001 ; 268: 4177-4182 (Pubitemid 32862878)
17. Gaevyi MD. Effect of cocarboxylase on tone of the intracranial and extracranial vessels and on the systemic arterial pressure. Bull Exp Biol Med. 1970 ; 70: 975-977
18. Widman M, Nilsson LB, Bryske B, Lundstrom J. Disposition of remoxipride in different species. Species differences in metabolism. Arzneimittel-Forschung. 1993 ; 43: 287-297 (Pubitemid 23093231)
19. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988 ; 34: 497-500
20. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem. 1968 ; 25: 192-205
21. Nabavi SF, Nabavi SM, Abolhasani F, Moghaddam AH, Eslami S. Cytoprotective effects of curcumin on sodium fluoride-induced intoxication in rat erythrocytes. Bull Environ Contamin Toxicol. 2012 ; 88: 486-490
22. Wei H, Frenkel K. In vivo formation of oxidized DNA bases in tumor promoter-treated mouse skin. Canc Res. 1991 ; 51: 4443-4449
23. Shigenaga MK, Aboujaoude EN, Chen Q, Ames BN. Assays of oxidative DNA damage biomarkers 8-oxo-2′-deoxyguanosine and 8-oxoguanine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection. Meth Enzymol. 1994 ; 234: 16-33
24. Kaur H, Halliwell B. Measurement of oxidized and methylated DNA bases by HPLC with electrochemical detection. Biochem J. 1996 ; 318 (Pt 1). 21-23 (Pubitemid 26283620)
25. Senturker S, Dizdaroglu M. The effect of experimental conditions on the levels of oxidatively modified bases in DNA as measured by gas chromatography-mass spectrometry: how many modified bases are involved? Prepurification or not?. Free Rad Biol Med. 1999 ; 27: 370-380 (Pubitemid 29395430)
26. Mosca F, Fattorini D, Bompadre S, Littarru GP. Assay of coenzyme Q(10) in plasma by a single dilution step. Anal Biochem. 2002 ; 305: 49-54 (Pubitemid 34575824)
27. Floyd RA, Watson JJ, Wong PK, Altmiller DH, Rickard RC. Hydroxyl free radical adduct of deoxyguanosine: sensitive detection and mechanisms of formation. Free Rad Res Commun. 1986 ; 1: 163-172
28. Asami S, Hirano T, Yamaguchi R, Tomioka Y, Itoh H, Kasai H. Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking. Canc Res. 1996 ; 56: 2546-2549 (Pubitemid 26170692)
29. Sugihara K, Gemba M. Modification of cisplatin toxicity by antioxidants. Jpn J Pharmacol. 1986 ; 40: 353-355 (Pubitemid 16180379)
30. Halliwell B, Gutteridge JMC Free radicals in biology and medicine. 4 th ed. New York, NY: Oxford University Press, 2007. New York, NY: Oxford University Press ; 2007 :
31. Smoorenburg GF, De Groot JC, Hamers FP, Klis SF. Protection and spontaneous recovery from cisplatin-induced hearing loss. Ann New York Acad Sci. 1999 ; 884: 192-210
32. Rybak LP, Husain K, Morris C, Whitworth C, Somani S. Effect of protective agents against cisplatin ototoxicity. Am J Otol. 2000 ; 21: 513-520 (Pubitemid 30432460)
33. Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res. 1998 ; 39: 1529-1542 (Pubitemid 28377917)
34. Slater TF. Free-radical mechanisms in tissue injury. Biochem J. 1984 ; 222: 1-15
35. Rodrigues MA, Rodrigues JL, Martins NM, et al. Carvedilol protects against cisplatin-induced oxidative stress, redox state unbalance and apoptosis in rat kidney mitochondria. Chem-Biol Inter. 2011 ; 189: 45-51
36. Sener G, Sehirli AO, Keyer-Uysal M, Arbak S, Ersoy Y, Yegen BC. The protective effect of melatonin on renal ischemia-reperfusion injury in the rat. J Pineal Res. 2002 ; 32: 120-126 (Pubitemid 34289590)
37. Hiraishi H, Terano A, Ota S, et al. Protection of cultured rat gastric cells against oxidant-induced damage by exogenous glutathione. Gastroenterology. 1994 ; 106: 1199-1207 (Pubitemid 24129235)
38. Suzuki M, Mori M, Miura S, et al. Omeprazole attenuates oxygen-derived free radical production from human neutrophils. Free Rad Biol Med. 1996 ; 21: 727-731 (Pubitemid 26331104)
39. Bast A, Haenen GR, Doelman CJ. Oxidants and antioxidants: state of the art. Am J Med. 1991 ; 91: 2S - 13S
40. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal: applications in research and therapy. Pharmacol therapeut. 1991 ; 51: 155-194
41. Urso ML, Clarkson PM. Oxidative stress, exercise, and antioxidant supplementation. Toxicology. 2003 ; 189: 41-54 (Pubitemid 36733566)
42. Turchi JJ, Patrick SM, Henkels KM. Mechanism of DNA-dependent protein kinase inhibition by cis-diamminedichloroplatinum(II)-damaged DNA. Biochemistry. 1997 ; 36: 7586-7593 (Pubitemid 27262385)
43. Turchi JJ, Li M, Henkels KM. Cisplatin-DNA binding specificity of calf high-mobility group 1 protein. Biochemistry. 1996 ; 35: 2992-3000 (Pubitemid 26086809)
44. Butterworth R. Modern nutrition in health and disease. 10 ed. Baltimore, MD: Lippincott Williams & Wilkins, 2005, pp. 426-433. ME Shils MS Ross AC Caballero B Cousins RJ, ed. Baltimore, MD: Lippincott Williams & Wilkins ; 2005, pp. 426-433 :
45. Roelofs RI, Hrushesky W, Rogin J, Rosenberg L. Peripheral sensory neuropathy and cisplatin chemotherapy. Neurology. 1984 ; 34: 934-938 (Pubitemid 14076460)
46. Thompson SW, Davis LE, Kornfeld M, Hilgers RD, Standefer JC. Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies. Cancer. 1984 ; 54: 1269-1275 (Pubitemid 14003522)
47. Novikoff PM, Novikoff AB, Quintana N, Hauw JJ. Golgi apparatus, gerl, and lysosomes of neurons in rat dorsal root ganglia, studied by thick section and thin section cytochemistry. J Cell Biol. 1971 ; 50: 859-886
48. Gregg RW, Molepo JM, Monpetit VJA, et al. Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphological evidence of toxicity. J Clin Oncol. 1992 ; 10: 795-803